United Therapeutics CEO Martine Rothblatt reports $4.45 million common share disposal - UTHR News | RalliesUnited Therapeutics CEO Martine Rothblatt reports $4.45 million common share disposal
U
UTHR• Insider option exercise and share sale reported
- United Therapeutics Chairperson and CEO Martine A. Rothblatt reported option exercise and share sales on July 17, 2026.
- A trust acquired 9,500 common shares via option exercise at $135.42.
- The same trust sold 9,500 common shares at weighted-average prices ranging from $528.91 to $542.43.
- Trust holdings fell to 324,443 common shares following the transactions.
